Stephen Webber

Company: Primmune Therapeutics

Job title: Vice President, Medicinal Chemistry & Co-founder

Seminars:

Workshop B: Advancing Translational Models for Improving Predictive Validity Within Innate Immune System-Targeted Therapies 7:00 am

This workshop aims to bridge the translational gap in the development of therapies targeting the innate immune system, with a specific focus on STING & TLR receptors. Attendees will gain insights into selecting, utilizing and validating translational models for effective translation of preclinical findings into clinical success. Overview of suitable preclinical models for evaluating STING…Read more

day: Conference Day 2